3-BETA-ACETOXY-16-BETA-[4-(4-TERT.-BUTYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
Compound with spectra: 1 NMR
![3-BETA-ACETOXY-16-BETA-[4-(4-TERT.-BUTYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL](/api/compound/5APqLl7fsdj.png?ph=true&h=300&w=458 "3-BETA-ACETOXY-16-BETA-[4-(4-TERT.-BUTYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL")
| SpectraBase Compound ID | 5APqLl7fsdj |
|---|---|
| InChI | InChI=1S/C34H47N3O3/c1-21(38)40-26-13-15-33(5)25(18-26)11-12-27-28(33)14-16-34(6)29(27)17-23(31(34)39)19-37-20-30(35-36-37)22-7-9-24(10-8-22)32(2,3)4/h7-11,20,23,26-29,31,39H,12-19H2,1-6H3/t23-,26+,27-,28+,29+,31+,33+,34+/m1/s1 |
| InChIKey | WQHVOEKRQQWSBO-CGCOXUHLSA-N |
| Mol Weight | 545.8 g/mol |
| Molecular Formula | C34H47N3O3 |
| Exact Mass | 545.361742 g/mol |
| Enantiomer InChIKey | WQHVOEKRQQWSBO-MLTQFGOXSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-BETA-ACETOXY-16-BETA-[4-(4-ETHYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(4-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-PHENYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
(16R) Ethyl 3,16-diacetoxy-20-methyl-24-nor-chol-5-en-23-oate
3.beta.,16.beta.-Diacetoxypregn-5-ene-20-carbaldehyde
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
3,17a-Diacetoxy-16a-methyleneacetoxy.delta. 5(6)-androsten
16-ALPHA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and In Vitro Antiproliferative Activity of Novel Androst-5-ene Triazolyl and Tetrazolyl Derivatives | Molecules | 2011 |